Please login to the form below

Not currently logged in
Email:
Password:

antimicrobial

This page shows the latest antimicrobial news and features for those working in and with pharma, biotech and healthcare.

Report finds ‘startling’ lack of progress of antibiotic R&D agenda

Report finds ‘startling’ lack of progress of antibiotic R&D agenda

The report looks at what has changed since the 2016 Review on Antimicrobial Resistance carried out by Jim O'Neill at the request of the UK Prime Minister. ... Antimicrobial resistance has become a higher-profile subject and there have been ‘significant

Latest news

More from news
Approximately 41 fully matching, plus 65 partially matching documents found.

Latest Intelligence

  • Evolution or revolution: the latest review of NICE methods Evolution or revolution: the latest review of NICE methods

    NICE has ruled out some areas this time around. They include genomic techniques and testing strategies, medical devices and diagnostics used to tackle antimicrobial resistance, as well as reviewing digital health

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    dementia and antimicrobials. ... It is focusing on four areas of acute medical and societal need where it believes healthcare comms can play a big role: antimicrobial resistance, mental health, obesity and precision medicine.

  • Combining therapies and combining research Combining therapies and combining research

    Antimicrobial resistance (AMR) is a complex issue of global concern that has the potential to void advances in modern medicine. ... There are growing concerns about the lack of new drug development surrounding antimicrobial resistance.

  • Rules of engagement Rules of engagement

    Fewer than half of the nearly 10, 000 respondents had heard of the term ‘antimicrobial resistance’.

  • No incentive for a cure No incentive for a cure

    The stakes are too high for this not to happen. The risk we face from antimicrobial resistance and the current lack of new antibiotics tells us all we need to know

More from intelligence
Approximately 6 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Mobilising the public to combat the antimicrobial resistance crisis

    Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. ... Her illness is due to antimicrobial resistance (AMR) and it is not as rare as you might think.

  • Navigating the antibiotic resistance crisis

    Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians navigating ... Antimicrobial resistance claims 5,

  • Antibiotic Resistance: Alarm bells ring louder than ever

    where antibiotics and the threat of antimicrobial resistance (AMR) became a hot topic in the mainstream media. ... Another angle is the development of small molecules that can be administered in conjunction with antimicrobials to prevent resistance

  • Cello Health

    Though international focus is turning to antimicrobial resistance and incentives are being provided for research into new drugs, there are many hurdles to be jumped before a blockbuster can be discovered

  • Blue Latitude Health

    Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. ... Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...
Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...

Infographics